Last weekend Dr. Chuck Jackson of Overall Ovations lead SUMO’s 2017 Board Retreat. We are feeling confident about the year to come and can’t wait to help Utah’s oncology staff care for their patients. Click Here for pictures of the … Continued
Location: Hyatt Centric Park City, UT Attendee Registration Physicians – $80 Non-Physicians – $40 Hotel Reservations: Rate – $209 Reserve your room today at 1-800-233-1234 by referring to “Society of Utah Medical Oncologists’ during booking. Fall Meeting Brochure Exhibitor Invitation/Registration
U.S. Food and Drug Administration approved ibrutinib (Imbruvica, Pharmacyclics LLC) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy. This is the first FDA-approved therapy for … Continued
U.S. Food and Drug Administration granted regular approval to enasidenib (IDHIFA, Celgene Corp.) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test.